FDA Warns Against Using Bo Ying Compound Due to Risk of Lead Poisoning
The U.S. Food and Drug Administration (FDA) is warning parents and caregivers not to use a particular alternative medicine because it contains high amounts of lead.
Manufactured by Eu Yan Sang (Hong Kong), Bo Ying Compound is marketed for infants and children as a treatment for a variety of ailments including the flu fever and sneezing. The New York City Department of Health & Mental Hygiene tested the supplement and found high levels of lead. The FDA also received one report of lead positing in a toddler after being given the supplement.
The product is sold online and in retail outlets and has labels in both English and Spanish.
The FDA says that exposure to lead can cause serious damage to the central nervous system, the kidneys, and the immune system. In children, chronic exposure to lead, even at low levels, is associated with impaired cognitive function, including reduced IQ, behavioral difficulties, and other problems.
Health care professionals and consumers are encouraged to report any adverse events potentially related to Bo Ying compound to the FDA's MedWatch Adverse Event Reporting program.